AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Global Eye Allergy Therapeutics Market Report 2019-2023 Featuring Akorn, Allergan, Bausch Health Companies, Novartis, & Santen Pharmaceutical - ResearchAndMarkets.com

May 28, 2019

DUBLIN--(BUSINESS WIRE)--May 28, 2019--

The “Global Eye Allergy Therapeutics Market 2019-2023” report has been added to ResearchAndMarkets.com’s offering.

This is expected to propel the growth of the market during the forecast period. Analysts have predicted that the eye allergy therapeutics market will register a CAGR of almost 5% by 2023.

The global eye allergy therapeutics market is currently witnessing a high unmet medical need for a once-daily double-action eye preparation for the treatment of various types of eye allergies. At present, the drugs administered for eye allergies are intended to treat symptoms such as redness and itching, and they provide substantial assistance to patients leaving approximately 20-30% of the patients untreated.

Also, the side effects associated with the available therapeutic options limit their use for a long duration. Therefore, the market is currently exhibiting a need for effective multiple-dose therapies that can treat the signs and symptoms of eye allergies with a quick onset of action and without side effects.

Market Overview

Significant comorbidity associated with eye allergies

All types of eye allergies are associated with chronic symptoms such as ocular itching inflammation redness and watery eyes, which are persistently disturbing, having an adverse effect on patients’ lives. This leads to loss of work performance decreased productivity and increased healthcare costs, which can put a significant economic burden on patients. To avoid the substantial comorbidity associated with eye allergies, people spend on the required therapeutics, which will drive the growth of the market during the forecast period.

Lack of awareness

The level of awareness about eye allergies is generally low. Media and the Internet were the primary sources of information for most people. The level of knowledge and awareness regarding eye allergies are low among medical students and was far lower among those with a non-medical background. The lack of awareness of the symptoms associated with eye allergies and the negligence in seeking medical help for their treatment are expected to limit the growth of the market during the forecast period.

Competitive Landscape

The market appears to be fragmented. The presence of several companies, including Akorn Inc. and Allergan Plc, the competitive environment is quite intense. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market’s competitive landscape and offering information on the products offered by companies. Bausch Health Companies Inc., Novartis AG, and Santen Pharmaceutical Co. Ltd. are some of the major companies covered in this report.

Key Topics Covered:

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

Preface

Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

Market ecosystem

Market characteristics

Market segmentation analysis

PART 04: MARKET SIZING

Market definition

Market sizing 2018

Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

Bargaining power of buyers

Bargaining power of suppliers

Threat of new entrants

Threat of substitutes

Threat of rivalry

Market condition

PART 06: EYE ALLERGY: AN OVERVIEW

PART 07: PIPELINE ANALYSIS

PART 08: MARKET SEGMENTATION BY PRODUCT

Market segmentation by product

Comparison by product

Antihistamines - Market size and forecast 2018-2023

Mast cell stabilizers - Market size and forecast 2018-2023

Corticosteroids - Market size and forecast 2018-2023

Immunomodulators - Market size and forecast 2018-2023

Others - Market size and forecast 2018-2023

Market opportunity by product

PART 09: CUSTOMER LANDSCAPE

PART 10: GEOGRAPHIC LANDSCAPE

Geographic segmentation

Geographic comparison

North America - Market size and forecast 2018-2023

Europe - Market size and forecast 2018-2023

Asia - Market size and forecast 2018-2023

ROW - Market size and forecast 2018-2023

Key leading countries

Market opportunity

PART 11: DECISION FRAMEWORK

PART 12: DRIVERS AND CHALLENGES

Market drivers

Market challenges

PART 13: MARKET TRENDS

PART 14: VENDOR LANDSCAPE

Overview

Landscape disruption

Competitive scenario

PART 15: VENDOR ANALYSIS

Vendors covered

Vendor classification

Market positioning of vendors

  • Akorn Inc.
  • Allergan Plc
  • Bausch Health Companies Inc.
  • Novartis AG
  • Santen Pharmaceutical Co. Ltd.

For more information about this report visit https://www.researchandmarkets.com/r/bymuho

View source version on businesswire.com:https://www.businesswire.com/news/home/20190528005667/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Allergy Drugs,Optical Disorders Drugs

KEYWORD:

INDUSTRY KEYWORD: HEALTH OPTICAL PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 05/28/2019 01:18 PM/DISC: 05/28/2019 01:18 PM

http://www.businesswire.com/news/home/20190528005667/en

All contents © copyright 2019 The Associated Press.All rights reserved.